NasdaqGS:SLM
NasdaqGS:SLMConsumer Finance

Assessing SLM Corporation (SLM) Valuation After Securities Class Action Lawsuits On Delinquency Disclosures

SLM (SLM) is back in focus after multiple securities class action lawsuits accused the lender of misleading investors about rising early stage delinquencies and the effectiveness of its loss mitigation and loan modification programs. See our latest analysis for SLM. That legal overhang sits against a mixed share price picture, with a 90 day share price return of 4.4% and a 1 year total shareholder return of 1.07%. However, the 30 day share price return of a 9.52% decline suggests momentum has...
NasdaqGS:OPEN
NasdaqGS:OPENReal Estate

Do Opendoor Technologies' New Incentive Hurdles Reframe Management Credibility For Investors In OPEN?

In early January 2026, Opendoor Technologies appointed Christy Schwartz as chief financial officer and Lucas Matheson as president, while granting performance-based stock awards tied to multi-tier share-price hurdles. These leadership changes and incentive structures, alongside initiatives such as blockchain exploration and the Homebuyer.com acquisition, signal a renewed emphasis on aligning management rewards with operational and market outcomes. We’ll explore how the new performance-linked...
NasdaqGS:LITE
NasdaqGS:LITECommunications

Will Lumentum’s (LITE) Accounting Transition Reshape Confidence in Its AI-Focused Investment Narrative?

Lumentum Holdings Inc. disclosed that Chief Accounting Officer and Senior Vice President, Finance, Matthew Sepe, plans to retire in fall 2026, with Eric Chang, a seasoned finance executive and certified public accountant, appointed to assume the Chief Accounting Officer role after the company files its quarterly report for the period ended December 27, 2025. The transition puts fresh focus on Lumentum’s financial leadership and reporting oversight just as investors await its upcoming fiscal...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Assessing Ultragenyx Pharmaceutical (RARE) Valuation After New DTX401 Filing And Setrusumab Phase 3 Results

Why recent trial and FDA milestones matter for Ultragenyx Pharmaceutical Ultragenyx Pharmaceutical (RARE) has just reported two key clinical milestones and completed a Biologics License Application submission for DTX401. These developments help frame how you might think about the stock at today’s levels. See our latest analysis for Ultragenyx Pharmaceutical. The recent DTX401 BLA submission and positive UX143 Phase 3 data arrive after a sharp 36.48% 1 month share price return decline and a...
NasdaqGS:ZION
NasdaqGS:ZIONBanks

Will Zions’ New Leadership Team and Sales Focus Shift Zions Bancorporation’s (ZION) Commercial Banking Narrative?

Zions Bank has recently undergone leadership changes, appointing executive vice president Nate Callister as CEO following Paul Burdiss’s departure and naming Christina Miles, a veteran commercial banker from Wells Fargo, as senior vice president and director of sales based in Boise. Together, these appointments signal a renewed emphasis on commercial banking depth and a more structured sales culture, with potential implications for how Zions executes on its growth and customer engagement...
NYSE:LHX
NYSE:LHXAerospace & Defense

Assessing L3Harris Technologies (LHX) Valuation After A Strong Run In Recent Months

Recent performance snapshot for L3Harris Technologies (LHX) L3Harris Technologies (LHX) has drawn attention after a period of solid stock performance, with the share price closing at $311.38 and recording positive returns over the past week, month, past 3 months, year and longer horizons. See our latest analysis for L3Harris Technologies. For context, L3Harris Technologies’ recent strength has come on top of a 56.33% total shareholder return over the past year. The 5.38% 7 day and 11.81% 30...
NasdaqGS:QCOM
NasdaqGS:QCOMSemiconductor

Qualcomm (QCOM) Valuation Check As CES 2026 Robotics Push Highlights Physical AI Expansion

Qualcomm (QCOM) is back in focus after using CES 2026 to showcase a full robotics stack centered on its new Dragonwing IQ10 processor, which targets industrial robots and advanced humanoids with on-device AI. See our latest analysis for QUALCOMM. The Dragonwing reveal comes after a string of CES announcements around Snapdragon X2 Plus PCs, automotive partnerships such as Toyota’s RAV4 using Snapdragon Digital Chassis, and ADAS software work with partners. The stock’s recent 90 day share price...
NYSE:ST
NYSE:STElectrical

Is Sensata Technologies Holding (ST) Attractively Priced After Recent Share Price Rebound?

If you are wondering whether Sensata Technologies Holding is offering fair value at its current price, this breakdown is designed to give you a clear, numbers first view of the stock. The share price closed at US$35.21 recently, with returns of 6.6% over the last 7 days, 4.9% over 30 days, 0.9% year to date and 26.0% over the past year. The 3 year and 5 year returns stand at a 16.8% decline and 34.4% decline respectively. These mixed returns over different time frames suggest that investors...
NasdaqGS:CLMT
NasdaqGS:CLMTOil and Gas

What Calumet (CLMT)'s 2025 Net Loss Guidance Means For Shareholders

In early January 2026, Calumet, Inc. issued preliminary guidance for 2025, saying it currently expects to post a net loss between US$69.0 million and US$12.0 million. This expected loss range provides an important reality check against earlier optimism around margin expansion and renewables growth, sharpening investor focus on execution and risk. We will now examine how Calumet’s newly guided 2025 net loss range affects its existing investment narrative around future margin...
NYSE:MCO
NYSE:MCOCapital Markets

Did Wall Street’s 2026 Debt-Issuance Optimism Just Reframe Moody’s (MCO) Risk-Analytics Narrative?

Earlier this week, Stifel upgraded Moody’s to Buy, joining Goldman Sachs and other brokers in expressing a broadly positive view on the risk assessment group’s prospects. The shift in analyst sentiment highlights growing optimism around Moody’s exposure to debt issuance and analytics businesses as demand for independent risk assessment evolves. We’ll now examine how this upgraded outlook for 2026 debt issuance could influence Moody’s existing investment narrative and long-term...
NasdaqGS:SBUX
NasdaqGS:SBUXHospitality

Is Starbucks (SBUX) Pricing Make Sense After Years Of Subdued Share Returns

If you are wondering whether Starbucks shares offer good value at current levels, it helps to separate the brand story from what the numbers are actually saying about the stock. The share price closed at US$86.56, with returns of 1.5% over the last 7 days, 1.7% over the last 30 days, 3.1% year to date and a 4.3% decline over the last year, alongside 12.2% and 5.8% declines over the last 3 and 5 years. Recent coverage has focused on how Starbucks is managing its global store footprint,...
NYSE:VZ
NYSE:VZTelecom

A Look At Verizon (VZ) Valuation As New CEO And Dividend Uncertainty Refocus Investor Attention

Verizon Communications (VZ) is under fresh scrutiny as a new CEO takes over just as its high dividend, recently around 6.8%, faces questions and prompts investors to reassess what they want from the stock. See our latest analysis for Verizon Communications. Verizon’s share price, now at US$40.23, has slipped over the past month with a 30 day share price return of 3.5% decline and a year to date share price return of 0.7% decline, while its 1 year total shareholder return of 10.5% points to...
NYSE:NET
NYSE:NETIT

Cloudflare (NET) Valuation Check As Multi Year Gains Contrast With Recent Share Price Softness

Cloudflare (NET) has caught investor attention after recent trading left the stock roughly flat over the month but lower over the past 3 months, prompting fresh questions about how its current valuation compares. See our latest analysis for Cloudflare. Looking beyond the recent softness, Cloudflare’s 1-year total shareholder return of 73.89% and very large 3-year total shareholder return of about 4x contrast with its weaker 90-day share price return of a 10.15% decline. This suggests momentum...
NasdaqGS:MGNI
NasdaqGS:MGNIMedia

How Investors May Respond To Magnite (MGNI) As Kopion Boosts Stake Amid CTV-Driven Growth

In the fourth quarter, Texas-based Kopion Asset Management increased its holdings in Magnite by 367,858 shares, about US$6.11 million based on average quarterly pricing, lifting the position to 7.13% of its 13F reportable assets, while Magnite reported 11% revenue growth and 13% adjusted EBITDA growth year over year, largely driven by connected TV advertising. Earlier this month, Magnite’s executives also met investors in person and hosted a webcast fireside chat at the Needham 28th Annual...
NasdaqGM:TTD
NasdaqGM:TTDMedia

Trade Desk (TTD) Is Up 5.2% After CES Spotlight On Kokai AI Platform – Has The Bull Case Changed?

The Trade Desk recently drew fresh attention after the CES 2026 conference, where its AI-powered advertising capabilities were highlighted amid broader enthusiasm for artificial intelligence across the technology sector. What stands out is how renewed focus on its AI-driven ad-buying tools has begun to reshape investor expectations for the company’s recovery path. With AI innovation in its Kokai ad-buying platform in the spotlight, we'll explore how this CES-fueled optimism may influence...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

Assessing Hologic (HOLX) Valuation After Recent Short Term Share Price Momentum

Hologic (HOLX) stock has been drawing interest as investors revisit its business profile, which spans diagnostics, breast health, GYN surgical and skeletal health, while they reassess recent share performance and earnings fundamentals. See our latest analysis for Hologic. At a recent share price of US$74.75, Hologic’s 90 day share price return of 9.38% contrasts with a more muted 1 year total shareholder return of 2.83% and slightly negative 3 and 5 year total shareholder returns. This...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean’s Upgraded 2025 Outlook and Expansion Plans Might Change The Case For Investing In RCL

Royal Caribbean Cruises has recently raised its full-year 2025 earnings guidance and outlined multi-year expansion plans, including new ships and exclusive destination resorts, following a strong post-pandemic recovery in passengers and profitability. An interesting angle for investors is the company’s aim to grow earnings per share by 20% annually through 2027 while also preserving its investment-grade bond rating, highlighting a balance between growth ambitions and balance sheet...
NYSE:BABA
NYSE:BABAMultiline Retail

Is Alibaba (BABA) Using Amap’s New 3D Tool To Quietly Reframe Its AI-Cloud Narrative?

In recent days, Alibaba Group Holding has expanded its AI-first push by rolling out an AutoNavi (Amap) tool that lets restaurants turn basic photos or videos into immersive 3D virtual tours, offered initially free to selected merchants. This move not only sharpens Alibaba’s rivalry with Meituan in local services but also showcases how its generative AI and cloud capabilities are being embedded into everyday commercial use cases. Next, we’ll examine how Alibaba’s new Amap 3D-visualization...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Assessing AST SpaceMobile (ASTS) Valuation After BlueBird 6 Launch And BlueBird 7 Progress

AST SpaceMobile (ASTS) is back in focus after the successful orbital launch of its BlueBird 6 satellite and the subsequent arrival of BlueBird 7 in Florida for launch vehicle integration. See our latest analysis for AST SpaceMobile. The recent surge in excitement around BlueBird 6 and BlueBird 7 has coincided with strong momentum in AST SpaceMobile shares, with a 30 day share price return of 23.0% and a 1 year total shareholder return of 295.3%. Multi year total shareholder return is also...
NYSE:NVO
NYSE:NVOPharmaceuticals

Is Novo Nordisk (NYSE:NVO) Attractive After Recent Share Price Weakness And DCF Upside?

If you are wondering whether Novo Nordisk is attractively priced right now, the key question is whether the current share price reflects its long term prospects or builds in too much optimism already. The stock last closed at US$55.11, with returns of 7.6% over the past week, 15.1% over the past month, 5.2% year to date, a 32.6% decline over the past year, a 14.5% decline over three years, and a 68.9% gain over five years. Recent headlines have continued to focus on Novo Nordisk's role in...
NasdaqGS:INTC
NasdaqGS:INTCSemiconductor

Why Intel (INTC) Is Up 5.5% After Launching Its 18A-Based Core Ultra Series 3 AI Platform

At CES 2026, Intel launched its Core Ultra Series 3 processors, the first AI PC platform built on the new 18A process and certified for both consumer laptops and industrial edge applications such as robotics, smart cities and healthcare. This marks a rare alignment of cutting-edge U.S.-manufactured PC chips with embedded and industrial certifications, positioning one architecture across mainstream AI PCs and demanding 24x7 edge workloads. We’ll now examine how Intel’s 18A-based Core Ultra...
NasdaqGS:IDCC
NasdaqGS:IDCCSoftware

Assessing InterDigital (IDCC) Valuation After A Strong Year And Mixed Recent Share Price Moves

InterDigital (IDCC) has drawn investor attention after recent trading left the shares with mixed short term returns and a strong 1 year total return, prompting a closer look at how the business fundamentals compare with the current price. See our latest analysis for InterDigital. The recent rebound, with a 1 day share price return of 2.94% and a 7 day share price return of 3.30%, follows a softer 30 day share price return of a 5.45% decline and a modest 90 day share price return of a 4.16%...
NasdaqGS:DLO
NasdaqGS:DLODiversified Financial

A Look At DLocal (DLO) Valuation After Governance Overhaul And Board Refresh

DLocal (NasdaqGS:DLO) is drawing attention after completing a governance reshuffle. The company has moved to a nine person, majority independent board and has added former senior executives from Citigroup and Google to its director lineup. See our latest analysis for DLocal. The governance refresh coincides with a recent pickup in momentum, with a 30 day share price return of 11.14% and a 1 year total shareholder return of 32.92% from a last close of US$14.77. However, the 3 year total...
NasdaqGS:BRKR
NasdaqGS:BRKRLife Sciences

Bruker (BRKR) Is Up 7.9% After Winning €35 Million ELI-NP Order In Romania

Recently, Bruker’s majority-owned RI Research Instruments secured approximately €35 million in orders for the Extreme Light Infrastructure – Nuclear Physics research project in Romania, creating a new revenue stream in advanced scientific infrastructure. This new business win has coincided with stronger analyst confidence in Bruker’s prospects, reflecting growing interest in its role supporting high-end research applications. Next, we’ll examine how this major research-infrastructure order...